The barely significant increase in CAD history in the low ATG group also supports this hypothesis.
← all excerpts
Immunophenotyping and efficacy of low dose ATG in non-sensitized kidney recipients undergoing early steroid withdrawal: a randomized pilot study.
1
—
—